NCT01804400View on ClinicalTrials.gov

A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

PHASE2CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Allergic Rhinitis
Interventions
DRUG

QAW039

DRUG

Montelukast

DRUG

Placebo

Trial Locations (1)

30625

Novartis Investigative Site, Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT01804400 - A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber | Biotech Hunter | Biotech Hunter